RxDoctor Payments Data

Niknam Eshraghi, MD

Surgery · Portland, ORNPI 1649364696

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Polynovo North America LLC accounts for 75.1% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $149, more than ten times the $11 reported in 2020. That places this record below the midpoint for surgery clinicians in OR, where the typical reported total is $1,338.

$431in general payments, 2019–2025

Across 15 payments — averaging $28.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Polynovo North America LLC$324
  • Integra Lifesciences Corporation$77
  • Solventum Corporation$19
  • Zimmer Biomet$11
$18,600in research payments, 2019–2025

Across 2 payments — averaging $9300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mallinckrodt Hospital Products Inc.$19K

What the payments were for

  • Food & beverage$431100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$431 in reported general payments places this provider in the 35th percentile of 386 surgery providers in Oregon.

See all surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$103,007
Medicare patients
73
Services billed
806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl15$89

Paid to pharmacies, not to this prescriber.

Other surgery in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →